NYSE$EHAB
Enhabit Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Headline financials
Revenue & EPS history
Enhabit · Revenue · Quarterly
$262M
Q2 2023-2.1%vs Q2 2022
Revenue by segment
Enhabit · $261M total across 2 segments · Q4 2024
- Home Health$210M—80.4%
- Hospice$51.1M—19.6%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 14 quarterly earnings reports · overlaid with Q2 2023
+1.9%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+8.6%
Avg return
30 days after
40%
6 / 15 earnings
Positive
+18.2%
Q1 2025
Best reaction
-6.1%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.1% | +0.1% | — | |
| Q4 2025 | +0.0% | +0.0% | +2.9% | |
| Q3 2025 | -6.1% | -2.7% | +13.6% | |
| Q2 2025 | +15.2% | +11.4% | +15.1% | |
| Q1 2025 | +18.2% | +27.7% | +31.7% | |
| Q4 2024 | +1.6% | +2.3% | +13.3% | |
| Q3 2024 | -0.4% | -5.7% | -12.0% | |
| Q2 2024 | +0.0% | -3.1% | +14.8% | |
| Q1 2024 | +0.0% | -5.4% | -13.4% | |
| Q4 2022 | +0.0% | -5.7% | -0.4% | |
| Q3 2023 | +6.1% | +6.7% | +19.3% | |
| Q2 2023 | -2.6% | -2.9% | +5.6% | |
| Q1 2023 | -4.5% | -6.0% | -2.0% | |
| Q3 2022 | -0.1% | +1.9% | +11.3% | |
| Q2 2022 | +1.7% | +5.1% | +20.6% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro